ANTIBODY FOR CELIAC DISEASE - ANVISA Registration 10303460561
Access comprehensive regulatory information for ANTIBODY FOR CELIAC DISEASE in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10303460561 and manufactured by IN VITRO DIAGNOSTICA LTDA. The registration is held by IN VITRO DIAGNOSTICA LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including ORGENTEC DIAGNOSTIKA GMBH, EUROIMMUN AG, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
10303460561
25351084154202553
42837716000198
Company Information
Dates and Status
Jun 30, 2025
VIGENTE
09/18/2025 19:00:01
ANTICORPO PARA DOENÇA CELÍACA
Família Autoteste Glúten
ZHEJIANG ORIENT GENE BIOTECH CO., LTD.
80113770055
Sep 15, 2025
ANTICORPO PARA DOENÇA CELÍACA
AESKUCARE® Gluten Related Disorders IgA
AESKU DIAGNOSTICS GMBH & CO. KG
80105220280
Jul 07, 2025
ANTICORPO PARA DOENÇA CELÍACA
Gliadin IgM
GA GENERIC ASSAYS GMBH
80464810926
Jul 07, 2025
ANTICORPO PARA DOENÇA CELÍACA
FAMÍLIA MAGLUMI® IgA Anti-DGP (CLIA)
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
81504790469
Mar 05, 2025
ANTICORPO PARA DOENÇA CELÍACA
FAMÍLIA MAGLUMI® IgG Anti-DGP (CLIA)
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
81504790470
Mar 05, 2025

